Compare Iovance Biotherapeutics Inc. Common Stock (IOVA) vs KraneShares Hang Seng TECH Index ETF (KTEC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Iovance Biotherapeutics Inc. Common Stock vs KraneShares Hang Seng TECH Index ETF — how do they compare? Iovance Biotherapeutics Inc. Common Stock trades at $14.43 (market cap $6.04B), while KraneShares Hang Seng TECH Index ETF trades at $11.67 (market cap $45.04M). The key difference: Iovance Biotherapeutics Inc. Common Stock is far larger — about 134.1× KraneShares Hang Seng TECH Index ETF's market cap, and Iovance Biotherapeutics Inc. Common Stock is trading nearer its 52-week high, KraneShares Hang Seng TECH Index ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Iovance Biotherapeutics Inc. Common Stock for 0 Days and KraneShares Hang Seng TECH Index ETF for 44 Days on average.
| IOVA | KTEC | |
|---|---|---|
Market Cap | $6.04B | $45.04M |
Volume | 14,805,993 | 29,043 |
Sector | Health | Sector/Thematic |
52-Week High | $14.82 | $18.73 |
52-Week Low | $1.81 | $11.41 |
Typical Hold Time | 0 Days | 44 Days |
Enterprise Value | $5.97B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Iovance Biotherapeutics Inc. Common Stock
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →About KraneShares Hang Seng TECH Index ETF
KTEC tracks the Hang Seng TECH Index, providing targeted exposure to the 30 largest technology companies listed on the Hong Kong Stock Exchange. It focuses on innovative, internet-based businesses across sectors like e-commerce, fintech, cloud computing, and digital technology.
Read more on KTEC →
